DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: QIAGEN N.V.
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

01.06.2022 / 22:04
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The AFM (the Netherlands Authority For the Financial Markets has informed us on May 31, 2022 that a notification related to our institution has been released by the AFM.

The following notification has been disclosed in the relevant register on the AFM website:

Date of transaction: 25 may 2022
Person obliged to notify: Goldman Sachs Group Inc., The
Issuing institution: Qiagen N.V.
Registration Chamber of Commerce: 12036979
Place of residence: VENLO

Distribution in numbers

Type of share	Number of shares	Number of voting rights	Capital interest	Voting rights	Manner of disposal	Settlement
Ordinary share	904.718,00	904.718,00	Potential	Potential	Indirectly - Goldman Sachs International	Physical Delivery
Convertible bond	323.592,00	323.592,00	Potential	Potential	Indirectly - Goldman Sachs International	Physical Delivery
Ordinary share	592.212,00	592.212,00	Potential	Potential	Indirectly - Goldman Sachs & Co. LLC	Physical Delivery
Option	3.863.782,00	3.863.782,00	Potential	Potential	Indirectly - Goldman Sachs & Co. LLC	Physical Delivery
Swap	17.617,00	17.617,00	Potential	Potential	Indirectly - Goldman Sachs & Co. LLC	In cash
Ordinary share	5.253,00	5.252,95	Real	Real	Indirectly - United Capital Financial Advisers, LLC	Physical Delivery
Ordinary share	43,00	43,00	Real	Real	Indirectly - Folio Investments Inc.	Physical Delivery
Swap	207.018,00	207.018,00	Potential	Potential	Indirectly - Goldman Sachs International	In cash
Ordinary share	27.927,00	27.926,72	Potential	Potential	Indirectly - Goldman Sachs Bank Europe SE	Physical Delivery
Warrant	39.743,00	39.743,00	Potential	Potential	Indirectly - Goldman Sachs Bank Europe SE	In cash
Ordinary share	19.785,00	19.784,80	Real	Real	Indirectly - The Goldman Sachs Trust Company of Delaware	Physical Delivery
Ordinary share	40.862,00	40.861,59	Real	Real	Indirectly - Goldman Sachs Bank Europe SE	Physical Delivery
Call-option	6.200,00	6.200,00	Potential	Potential	Indirectly - Goldman Sachs & Co. LLC	Physical Delivery
Ordinary share	26.853,00	26.852,73	Real	Real	Indirectly - NN Investment Partners Holdings N.V.	Physical Delivery
Convertible bond	520.202,00	520.202,00	Potential	Potential	Indirectly - NN Investment Partners Holdings N.V.	Physical Delivery

Distribution in percentages

Type	Total holding	Directly real	Directly potential	Indirectly real	Indirectly potential
Capital interest	2,86 %	0,00%	0,00%	0,04%	2,82%
Voting rights	2,86 %	0,00%	0,00%	0,04%	2,82%

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has
been taken from the relevant register of the AFM:
https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=125192

01.06.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	QIAGEN N.V.
	Hulsterweg 82
	5912 PL Venlo
	Netherlands
Internet:	www.qiagen.com


End of News	DGAP News Service

1364695 01.06.2022

Aktienempfehlungen zu QIAGEN N.V.

12.08.22	QIAGEN Buy	Deutsche Bank AG
29.07.22	QIAGEN Overweight	JP Morgan Chase & Co.
28.07.22	QIAGEN Hold	Jefferies & Company Inc.
27.07.22	QIAGEN Kaufen	DZ BANK
27.07.22	QIAGEN Buy	Deutsche Bank AG
mehr Aktienempfehlungen

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:
Kaufwert:	EUR
Cancel	Hinzufügen Speichern

DGAP-CMS: QIAGEN N.V.: Release of a capital market information (EQS Group)	29.07.22
ROUNDUP: Qiagen wird trotz Umsatzrückgang optimistischer - Aktie legt zu (dpa-AFX)	27.07.22
DGAP-Adhoc: QIAGEN N.V.: QIAGEN erhöht Ausblick für das Gesamtjahr 2022 (EQS Group)	26.07.22
DGAP-Adhoc: QIAGEN N.V.: QIAGEN increases full-year 2022 outlook (EQS Group)	26.07.22
Qiagen – Ausbruch aus der Range (Société Générale)	15.06.22
DGAP-DD: QIAGEN N.V. english (EQS Group)	10.06.22
DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)	08.06.22
DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)	01.06.22
mehr

17.02.21	QIAGEN Verkaufen	Independent Research GmbH
14.12.20	QIAGEN Verkaufen	DZ BANK
10.12.20	QIAGEN Verkaufen	Independent Research GmbH
24.11.20	QIAGEN Verkaufen	Independent Research GmbH
11.11.20	QIAGEN Verkaufen	DZ BANK
mehr Aktienempfehlungen

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:
Kaufwert:	EUR
Cancel	Hinzufügen Speichern

DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Eintrag hinzufügen Eintrag bearbeiten

Aktien in diesem Artikel

Nachrichten zu QIAGEN N.V.

Aktienempfehlungen zu QIAGEN N.V.

Eintrag hinzufügen Eintrag bearbeiten

Nachrichten